Amanda Gordon

Phase III Randomized Trial of Docetaxel-Carboplatin Versus Paclitaxel-Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

P. Vasey, Gordon C. Jayson, Amanda Gordon et al. · JNCI Journal of the National Cancer Institute · 2004 · 638 citations · Full text

Medicine, Oncology, Pharmacology +16

A Feasibility Trial of Antiangiogenic (Metronomic) Chemotherapy in Pediatric Patients With Recurrent or Progressive Cancer

Mark W. Kieran, Christopher Turner, Joshua B. Rubin et al. · Journal of Pediatric Hematology/Oncology · 2005 · 202 citations

Medicine, Oncology, Pharmacology +17

On behalf of the Scottish Gynaecological Cancer Trials Group. Phase III Randomized Trial of Docetaxel?Carboplatin Versus Paclitaxel?Carboplatin as First-line Chemotherapy for Ovarian Carcinoma

Vasey Pa, Gordon C. Jayson, Amanda Gordon et al. · JNCI Journal of the National Cancer Institute · 2004 · 128 citations

Medicine, Gynecology, Oncology +12

Combined lenalidomide, low‐dose dexamethasone, and rituximab achieves durable responses in rituximab‐resistant indolent and mantle cell lymphomas

Tahamtan Ahmadi, Elise A. Chong, Amanda Gordon et al. · Cancer · 2013 · 46 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

A rapid genotyping panel for detection of primary central nervous system lymphoma

Mihir Gupta, Evan Burns, N. Zeke Georgantas et al. · Blood · 2021 · 41 citations · Full text

Medicine, Neurology, Oncology +11